not tagged
not tagged
['dlbcl', 'nordic']
 nlg-lbc-06. nordic study for high risk dlbcl. impact of ctdna and tp53. promising ffs, pfs, os.
da-epoch r could overcome r.f. apart fr p53, ctdna. ctdna burden transl to poorer outcome. tp53 as well. eot pet ds 5 and eot mrd predicted survival.
#17icml 
Oncologist at Uppsala university hospital. Chair of the Swedish lymphoma group (SLG) and the Swedish Hodgkin lymphoma group.